Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
85.14%
-
Total 13F principal
-
$311,049,000
-
Principal change
-
-$11,378,888
-
Total reported market value
-
$265,754,000
-
Number of holders
-
33
-
Value change
-
-$11,103,578
-
Number of buys
-
17
-
Number of sells
-
13
Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q2 2019
As of 30 Jun 2019,
ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by
33 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$311,049,000
in principal (par value) of the bond.
The largest 10 bondholders included
UBS OCONNOR LLC, D. E. Shaw & Co., Inc., CANYON CAPITAL ADVISORS LLC, SYMPHONY ASSET MANAGEMENT LLC, Jefferies Group LLC, WELLS FARGO & COMPANY/MN, CAPSTONE INVESTMENT ADVISORS, LLC, Partner Fund Management, L.P., Davidson Kempner Capital Management LP, and DEUTSCHE BANK AG\.
This page lists
33
institutional bondholders reporting positions
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.